Delivery Order SPE2DB20D2104-SPE2DB26FMAUB
Award Date 10/23/25
Potential Completion Date 10/24/25
Potential Value $5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $46,224.65 for Xeljanz XR 11 mg tablets (30-count unit of use packaging) on April 24, 2025, with completion scheduled for April 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of AmerisourceBergen's ongoing supply of pharmaceutical products to federal medical procurement needs. The place of performance is...
- The Defense Logistics Agency awarded a $5,031.72 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Xeljanz XR 11 mg tablets (30-count unit dose packaging). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 26, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Xeljanz XR 11 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $3,198.50, was competitively awarded without set-aside designation and is scheduled for completion by August 22, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a delivery order valued at $3,012.98 to AmerisourceBergen Drug Corp for the supply of Xeljanz 5 mg tablets (60-count units) on September 11, 2025, with completion anticipated by September 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Xeljanz XR 11 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $18,726.08 and an ultimate completion date of October 22, 2025. The contract was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Xeljanz XR 11 mg tablets in quantities of 30 per unit, with a ceiling value of $1,709.94. This firm fixed-price delivery order, with an ultimate completion date of August 29, 2025, represents a non-set-aside competitive award issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $5,350.64 to AmerisourceBergen Drug Corp for XELJANZ XR 11 mg tablets (30-count units) on July 30, 2025, with a completion date of July 31, 2025. This firm fixed price delivery order represents a competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a $5,682.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Xeljanz XR 11 mg tablets (30-count units), with an ultimate completion date of June 3, 2025. This non-set-aside contract represents a competitively awarded pharmaceutical procurement supporting federal medical supply needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded a delivery order valued at $48,448.63 to AmerisourceBergen Drug Corp for the supply of Xeljanz 10 mg tablets (60-count units) with a completion date of September 29, 2025. This is a firm fixed-price, non-set-aside contract awarded competitively on September 26, 2025. The pharmaceutical will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents one...
- The Defense Logistics Agency awarded a $3,914.17 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Xeljanz XR 11 mg tablets in quantities of 30 units. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 18, 2025. The delivery order is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...